Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
复制标题
受控物质附表：将氢可酮组合产品从附表 III 重新安排到附表 II。
作者：
D. Baehren;Catherine A. Marco;Danna Droz;S. Sinha;E. M. Callan;P. Akpunonu
随着这一最终规则的发布，美国缉毒署署长将氢可酮复方产品从《管制物质法》附表三调整为附表二。这一列表行动是根据《管制物质法》采取的，该法要求在有机会通过正式规则制定进行听证后，将此类行动记录在案。该行动对处理（制造、分销、分发、进口、出口、从事研究、开展教学活动、进行化学分析或拥有）或拟处理氢可酮组合产品的人员实施适用于附表二受控物质的监管控制和行政、民事和刑事制裁。
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration reschedules hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule II controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities with, conduct chemical analysis with, or possess) or propose to handle hydrocodone combination products.